Peter Nell

USPTO Granted Patents = 24 (Patent Applications = 3)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 7)

Average Co-Inventor Count = 9.2

ph-index = 5

Forward Citations = 83(Granted Patents)

Location History:

Woodside, CA (US) (2012 - 2015)
Wuppertal, DE (2007 - 2023)

Company Filing History:

15 out of 721

Bayer Intellectual Property Gmbh

patents

3 out of 76

Bayer Healthcare Aktiengesellschaft

patents

3 out of 53

Aicuris Gmbh + Co. Kg.

patents

4. 1 out of 192

Bayer Schering Pharma Ag

patents

5. 1 out of 9

Aicuris Anti-infective Cures Gmbh

Years Active: 2007-2023

Loading Chart...

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. RE49698 - Substituted dihydroquinazolines (2023-10-17),

2. RE46791 - Substituted dihydroquinazolines (2018-04-16),

3. 9205077 - 2-alkoxy-substituted dicyanopyridines and their use (2015-12-08),

4. 9187428 - Substituted dicyanopyridines and use thereof (2015-11-17),

5. 9095582 - Substituted aryloxazoles and their use (2015-08-04),

6. 8791146 - 2-alkoxy-substituted dicyanopyridines and their use (2014-07-29),

7. 8772498 - Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof (2014-07-08),

8. 8741834 - Dipeptoid prodrugs and the use thereof (2014-06-03),

9. 8703934 - Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof (2014-04-22),

10. 8691850 - Substituted phenylaminothiazoles and use thereof (2014-04-08),

11. 8653109 - Substituted bipyridine derivatives and their use as adenosine receptor ligands (2014-02-18),

12. 8618119 - Fused cyanopyridines and the use thereof (2013-12-31),

13. 8609686 - Substituted azabicyclic compounds and the use thereof (2013-12-17),

14. 8513255 - Substituted dihydroquinazolines (2013-08-20),

15. 8440700 - Substituted aryloxazoles and their use (2013-05-14),

Certainly! Here is an article about inventor Peter Nell:

Title: Peter Nell: Pioneer in Technology Innovation

Introduction:

Peter Nell, a visionary inventor based in Wuppertal, Germany, is renowned for his passion for innovation and his unwavering dedication to creating a positive impact through his groundbreaking inventions. With a remarkable portfolio of 24 patents to his name, Nell has solidified his position as a true pioneer in the world of technology.

Latest Patents:

Among his latest patents is the invention of Substituted dihydroquinazolines. This innovative technology not only introduces new processes for preparation but also highlights its significant potential in treating and preventing diseases, particularly as antiviral agents against cytomegalo viruses.

Career Highlights:

Having worked with prestigious companies such as Bayer Intellectual Property GmbH and Bayer Healthcare Aktiengesellschaft, Nell has honed his skills and expertise in driving technological advancements in the healthcare sector. His contributions have not only revolutionized the field but have also laid the foundation for future innovation.

Collaborations:

Throughout his career, Peter Nell has collaborated with esteemed professionals in the industry, including Alexandros Vakalopoulos and Barbara Albrecht-Küpper. These collaborations have enriched his work, fostering a culture of creativity and excellence in innovation.

Conclusion:

Peter Nell's remarkable journey as an inventor underscores his commitment to pushing the boundaries of technology and making a lasting impact on society. His relentless pursuit of innovation and his pioneering spirit continue to inspire the next generation of inventors to strive for greatness in the ever-evolving world of technology.

Please let me know if you need any further information or assistance.

This text is generated by artificial intelligence and may not be accurate.